Invention Grant
- Patent Title: Compositions and methods for inhibiting nuclear receptor subfamily 1 group H member 3 (NR1H3) expression
-
Application No.: US17724176Application Date: 2022-04-19
-
Publication No.: US11578329B2Publication Date: 2023-02-14
- Inventor: Utsav Saxena , Henryk Dudek , Natalie Wayne Pursell , Nicole Alexis Spiegelman , Markus Robert Latta , Birgitte Andersen
- Applicant: Novo Nordisk A/S , Dicerna Pharmaceuticals, Inc.
- Applicant Address: DK Bagsvaerd; US MA Lexington
- Assignee: Novo Nordisk A/S,Dicerna Pharmaceuticals, Inc.
- Current Assignee: Novo Nordisk A/S,Dicerna Pharmaceuticals, Inc.
- Current Assignee Address: DK Bagsvaerd; US MA Lexington
- Agent Jianjie Hu
- Priority: EP21186366 20210719,EP21213711 20211210
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61P1/16 ; A61P3/06
Abstract:
Oligonucleotides are provided herein that inhibit NR1H3 expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with NR1H3 expression.
Public/Granted literature
- US20220340912A1 COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3 (NR1H3) EXPRESSION Public/Granted day:2022-10-27
Information query
IPC分类:
